NOFI AS Company Overview, Contact Details & Competitors

Q: What is NOFI AS's official website and social media links?

NOFI AS's official website is nofi.no. NOFI AS has social profiles on LinkedIn.

Q: How many employees does NOFI AS have currently?

NOFI AS has approximately 51 employees.

Q: What technology does NOFI AS use?

NOFI AS's tech stack includes Google Maps, PHP, Google AdSense, Apache, Facebook.

Insights

Gathering insights about NOFI AS…

Similar companies to NOFI AS

NOFI AS Tech Stack

NOFI AS uses 8 technology products and services including jsDelivr, Google Hosted Libraries, Swiper, and more. Explore NOFI AS's tech stack below.

jsDelivr
Content Delivery Network
Google Hosted Libraries
Content Delivery Network
Swiper
Javascript Libraries
AOS
Javascript Libraries
PHP
Programming Languages
HSTS
Security
Google Tag Manager
Tag Management
Apache HTTP Server
Web Servers

Media & News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY
NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sanofi ("Sanofi" or the "Company") (NASDAQ:SNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Jun 04, 2025 | www.accessnewswire.com
SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease
Sanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.
Jun 04, 2025 | www.zacks.com
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Blueprint Medicines Corporation (NasdaqGS: BPMC) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Blueprint will receive $129.00 per share in cash at closing, and also will receive one non-tradeable contingent value right (CVR) entitling the holder to rece.
Jun 03, 2025 | www.businesswire.com
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety compared to intravenous infusion Studies used Enable Injections' enFuse® on-body injector, an automated hands-free injector Data will form the basis of global regulatory submissions across all currently approved lines of treatment Paris, June 3, 2025. New data from two clinical studies of the investigational use of Sarclisa administered subcutaneously (SC) via an on-body injector (OBI) (also referred to as an on-body delivery system) in relapsed or refractory multiple myeloma (R/R MM) support the potential use of this innovative delivery method to advance patient care, while upholding Sarclisa's efficacy and safety profile.
Jun 03, 2025 | www.globenewswire.com
Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz
Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the impact of tariffs on pharmaceuticals and how to trade in the sector.
Jun 02, 2025 | www.youtube.com
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines
SNY's $9.5 billion deal to acquire BPMC boosts its immunology pipeline and adds fast-growing Ayvakit to its portfolio.
Jun 02, 2025 | www.zacks.com
Johnson Fistel Investigates Fairness of Proposed Sale of Blueprint Medicines
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP has launched an investigation into whether the board members of Blueprint Medicines Corporation (NASDAQ: BPMC) breached their fiduciary duties in connection with the proposed sale of the Company to Sanofi (NASDAQ: SNY).
Jun 02, 2025 | www.globenewswire.com

NOFI AS's Email Address Formats

NOFI AS uses at least 1 format(s):

NOFI AS Email Formats	Example	Percentage
First@nofi.no	John@nofi.no	50%
First@nofi.no	John@nofi.no	50%

Frequently Asked Questions

What is NOFI AS's stock symbol?

NOFI AS is a publicly traded company; the company's stock symbol is SNY.

What is NOFI AS's official website and social media links?

NOFI AS's official website is nofi.no and has social profiles on LinkedIn.

What is NOFI AS's NAICS code?

NOFI AS's NAICS code is 31-33 - Manufacturing.

How many employees does NOFI AS have currently?

As of December 2025, NOFI AS has approximately 51 employees across 3 continents, including EuropeAfricaNorth America. Key team members include It Manager: L. C. F.R&d Manager: D. N.Purchasing And Logistics Manager: T. M. F.. Explore NOFI AS's employee directory with LeadIQ.

What industry does NOFI AS belong to?

NOFI AS operates in the Manufacturing industry.

What technology does NOFI AS use?

NOFI AS's tech stack includes jsDelivrGoogle Hosted LibrariesSwiperAOSPHPHSTSGoogle Tag ManagerApache HTTP Server.

What is NOFI AS's email format?

NOFI AS's email format typically follows the pattern of First@nofi.no. Find more NOFI AS email formats with LeadIQ.

When was NOFI AS founded?

NOFI AS was founded in 1978.

Insights

Similar companies to NOFI AS

Elastec

DESMI A/S

Marine Spill Response Corporation

NRC

Polyeco Group

NOFI AS Tech Stack

Media & News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY

SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines

Johnson Fistel Investigates Fairness of Proposed Sale of Blueprint Medicines

NOFI AS's Email Address Formats

Frequently Asked Questions

What is NOFI AS's stock symbol?

What is NOFI AS's official website and social media links?

What is NOFI AS's NAICS code?

How many employees does NOFI AS have currently?

What industry does NOFI AS belong to?

What technology does NOFI AS use?

What is NOFI AS's email format?

When was NOFI AS founded?

NOFI AS

Company Overview

Media & News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY

SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?